login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
CINCOR PHARMA INC (CINC) Stock News
USA
- NASDAQ:CINC -
US17240Y1091
-
Common Stock
29.06
USD
-0.14 (-0.48%)
Last: 2/23/2023, 8:00:00 PM
29.25
USD
+0.19 (+0.65%)
After Hours:
2/23/2023, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CINC Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: CinCor Pharma Inc
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
3 years ago - By: Benzinga
Where CinCor Pharma Stands With Analysts
3 years ago - By: Investor's Business Daily
- Mentions:
AZN
AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout
3 years ago - By: Benzinga
- Mentions:
ARWR
CERS
CUTR
RVNC
...
12 Health Care Stocks Moving In Monday's Intraday Session
3 years ago - By: Kahn Swick & Foti, LLC
CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC
3 years ago - By: The Motley Fool
- Mentions:
AZN
ALBO
Why These Two Biotech Stocks Blasted Higher This Week
3 years ago - By: Investor's Business Daily
- Mentions:
TSLA
JPM
UNH
TSM
...
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
3 years ago - By: Kahn Swick & Foti, LLC
CINCOR PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC
3 years ago - By: Weiss Law
- Mentions:
AZN
SHAREHOLDER ALERT: Weiss Law Investigates CinCor Pharma, Inc.
3 years ago - By: Seeking Alpha
- Mentions:
COIN
MARA
HUT
RIOT
...
Hot Stocks: Crypto stocks rally; CINC, ALBO soar on M&A news; LULU slumps on guidance
3 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether CinCor Pharma, Inc. has obtained a Fair Price in its transaction with AstraZeneca
3 years ago - By: Investor's Business Daily
- Mentions:
AZN
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal
3 years ago - By: InvestorPlace
- Mentions:
AZN
BBBY
BABA
TSLA
Why Is CinCor (CINC) Stock Up 138% Today?
3 years ago - By: Halper Sadeh LLC
CINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CinCor Pharma, Inc. Is Fair to Shareholders
Please enable JavaScript to continue using this application.
